INCREASED RISK OF LUNG-CANCER IN THE MELTING DEPARTMENT OF A 2ND ONTARIO STEEL MANUFACTURER

被引:16
|
作者
FINKELSTEIN, MM [1 ]
BOULARD, M [1 ]
WILK, N [1 ]
机构
[1] ONTARIO MINIST LABOUR,HLTH & SAFETY SUPPORT SERV BRANCH,HAMILTON,ONTARIO,CANADA
关键词
INDUSTRIAL HYGIENE; SILICA; SMOKING; EPIDEMIOLOGY; STEEL POURING;
D O I
10.1002/ajim.4700190206
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A study of lung cancer among workers at an electric arc steel making operation was performed to follow up on the observation of a lung cancer cluster in the melt shop of another plant. The study group comprised 335 deceased men identified from plant records. Eight of thirty men who had ever worked in the pouring pit area died of lung cancer (PMR 276; p < 0.01), but increased risk was not found elsewhere in the melting department. There was a significant trend in lung cancer risk with the length of employment in the pit area during a time window 18-30 years before death. Smoking data suggested that smoking alone could not account for the increased risk. An industrial hygiene assessment found present exposures to carcinogenic metals and silica to be within current guidelines. No polycyclic aromatic hydrocarbons were detected. This is the second steel plant for which we have found increased lung cancer risk in the pouring areas. The causative factors have not yet been identified.
引用
收藏
页码:183 / 194
页数:12
相关论文
共 50 条
  • [41] METACHRONOUS LUNG-CANCER IMPORTANCE OF EARLY DIAGNOSIS AND FOLLOW-UP AFTER 2ND SURGICAL RESECTION
    MOUSSET, X
    DESLAURIERS, J
    BEAULIEU, M
    DESPRES, JP
    PIRAUX, M
    FOURNIER, B
    LAVALLEE, J
    SAINTPIERRE, C
    [J]. ANNALES DE CHIRURGIE, 1989, 43 (08): : 658 - 662
  • [42] Highlights of the 2nd European Lung Cancer Conference
    Girard, Nicolas
    Mornex, Francoise
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (07) : 1023 - 1025
  • [43] ANTIGENS OF LUNG-CANCER - RESULTS OF THE 2ND-INTERNATIONAL-WORKSHOP-ON-LUNG-CANCER-ANTIGENS
    SOUHAMI, RL
    BEVERLEY, PCL
    BOBROW, LG
    LEDERMANN, JA
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (09) : 609 - 612
  • [44] The Feasibility of Lung Second Surgery for 2nd Primary Lung Cancer
    Hata, Kazunori
    Suzuki, Kenji
    Matsunaga, Takeshi
    Takamochi, Kazuya
    Oh, Shiaki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S772 - S773
  • [45] THE ABSENCE OF INCREASED LUNG-CANCER RISK AT LOW-LEVELS OF ASBESTOS EXPOSURE
    BROWNE, K
    [J]. CHEST, 1987, 91 (02) : 300 - 300
  • [47] RELATION OF FORCED EXPIRATORY VOLUME IN ONE 2ND (FEV1) TO LUNG-CANCER MORTALITY IN THE MULTIPLE RISK FACTOR INTERVENTION TRIAL (MRFIT)
    KULLER, LH
    OCKENE, J
    MEILAHN, E
    SVENDSEN, KH
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (02) : 265 - 274
  • [48] CISPLATINUM, VP-16, AND VINDESINE AS 2ND LINE THERAPY IN ACO REFRACTORY SMALL CELL LUNG-CANCER
    GATZEMEIER, U
    RADENBACH, D
    [J]. TUMORDIAGNOSTIK & THERAPIE, 1985, 6 (05) : 203 - 205
  • [49] CARBOPLATIN AS 2ND LINE TREATMENT FOR RECURRENT OR PROGRESSIVE BRAIN METASTASES FROM SMALL-CELL LUNG-CANCER
    GROEN, HJM
    SMIT, EF
    HAAXMAREICHE, H
    POSTMUS, PE
    [J]. EUROPEAN JOURNAL OF CANCER, 1993, 29A (12) : 1696 - 1699
  • [50] 2ND CANCER RISK AFTER INTERFERON THERAPY
    TROUSSARD, X
    HENRYAMAR, M
    FLANDRIN, G
    [J]. BLOOD, 1994, 84 (09) : 3242 - 3244